FMC (FMC) News Today

FMC Corporation (NYSE: FMC) shares increased as investors focused on the company’s better-than-expected second-quarter adjusted earnings and cash generation, although the rally is tempered by weaker revenue and reduced guidance.

• Positive Sentiment: FMC reported second-quarter adjusted EPS of $0.26, above the $0.21 analyst consensus. Adjusted EBITDA of $153 million also exceeded the high end of management’s guidance range. FMC Tops Q2 Earnings Estimates
• Positive Sentiment: Cash flow improved significantly, with operating cash flow reaching $363 million, up $297 million year over year. FMC also raised its free-cash-flow outlook to $75 million-$225 million, including a $200 million upfront payment from its rimisoxafen licensing agreement. FMC Reports Second-Quarter 2026 Results
• Positive Sentiment: Planned transactions—including the India business sale, licensing agreement, Newark property sale-leaseback and Tessenderlo Group investment—are expected to generate approximately $1 billion for debt reduction. An FMC director also purchased 18,072 shares recently, providing a limited insider-confidence signal. FMC Q2 Revenue Falls 17 Percent
• Neutral Sentiment: Wolfe Research maintained a Hold rating, citing the modest earnings beat but noting that FMC’s outlook and longer-term structural challenges remain unresolved. FMC Guidance and Structural Headwinds
• Negative Sentiment: Revenue fell 17% year over year to $867 million, organic revenue declined 22%, and adjusted EPS dropped 62% from $0.69 a year earlier. FMC also posted a $187 million GAAP net loss. FMC Earnings Report
• Negative Sentiment: Management cut full-year 2026 adjusted EPS guidance to $1.19-$1.49 from expectations of $1.68, reduced revenue guidance to $3.5 billion-$3.7 billion, and forecast third-quarter EPS well below consensus. The lowered outlook reflects a more challenging macro environment and continued demand pressure. FMC Updated Full-Year Outlook